Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bevit-B12 is a combination of three essential B vitamins: thiamine (vitamin B1), pyridoxine (vitamin B6), and cyanocobalamin (vitamin B12). Developed and marketed by Berko İlaç, it is indicated for the treatment and prevention of vitamin B1, B6, and B12 deficiencies, as well as for the management of various neurological and musculoskeletal conditions such as neuritis, polyneuritis, diabetic neuropathy, neuralgia, shingles, arthritis, back pain, muscle pain, and rheumatic pain. Thiamine is involved in carbohydrate metabolism and nerve impulse conduction; pyridoxine plays a key role in amino acid metabolism and nervous system function; and cyanocobalamin is essential for hematopoiesis and myelin synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cyanocobalamin + pyridoxine + thiamine.